News Headlines Article

Good Samaritan Hospital Chosen to Investigate Novel Treatment Option for Peripheral Arterial Disease
Sacramento Bee

Good Samaritan Hospital in Los Angeles is participating in the Levant 2 clinical trial to investigate a potential new treatment option for people with peripheral artery disease (PAD). The clinical trial will help doctors determine whether a drug coated angioplasty balloon will be more successful in keeping narrowed arteries open for longer compared to treatment with a non-coated standard angioplasty balloon.